Ciproflox-dexameth otic susp 7.5ML
Ended Awarded
- Contract number
- SPE2DB25FQRJL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,542
Award facts
- Contract value 100% obligated
- $2,542.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $2,542.02 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, with an ultimate completion date of July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made on a non-set-aside, competitively awarded basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems, with the place of performance identified as Conshohocken, PA.
The underlying IDC vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. Through this contract structure, the company delivers specialty medications, brand-name and generic drugs, vaccines, and other medical commodities across multiple therapeutic domains. This specific delivery order for the ophthalmic antibiotic-corticosteroid combination suspension reflects the vendor's continued participation in DLA's pharmaceutical supply chain, supporting military medical readiness requirements.
Quick answers
Who was awarded contract SPE2DB25FQRJL?
SPE2DB25FQRJL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FQRJL worth?
The government has obligated $2,542 on SPE2DB25FQRJL.
Is contract SPE2DB25FQRJL an order under another contract?
Yes. SPE2DB25FQRJL is a delivery order under SPE2DB25D2207, an indefinite delivery contract.
Was contract SPE2DB25FQRJL competed?
The extent of competition for SPE2DB25FQRJL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award